Men Most Likely to Undergo Challenging Study Procedures Identified in Prostate Cancer Prevention Trial

Men Most Likely to Undergo Challenging Study Procedures Identified in Prostate Cancer Prevention Trial
finasterideResearchers at The University of Texas MD Anderson Cancer Center and the Fred Hutchinson Cancer Research Center, Seattle, have published their results on the Prostate Cancer Prevention Trial, whereby healthy men actively participating in all the steps of the trial are most likely to undergo a biopsy. The study, entitled “Factors Associated with Adherence to an End-of-Study Biopsy: Lessons from the Prostate Cancer Prevention Trial (SWOG-Coordinated Intergroup Study S9217)” and published in the Cancer Epidemiology, Biomarkers and Prevention journal, analyzed patients undergoing a 7-year randomized, double-blind, placebo-controlled trial to assess the efficacy of finasteride, a synthetic drug for the treatment of benign prostatic hyperplasia, in the prevention of prostate cancer. The researchers designed a systematic model to identify factors associated with men adhering to the end-of-study (EOS) biopsy requirement of the trial, an invasive procedure that histologically detects whether or not cancer cells ar
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *